Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Chemed Corporation (CHE : NYSE)
 
 • Company Description   
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.

Number of Employees: 15,811

 
 • Price / Volume Information   
Yesterday's Closing Price: $511.13 Daily Weekly Monthly
20 Day Moving Average: 150,948 shares
Shares Outstanding: 13.27 (millions)
Market Capitalization: $6,784.79 (millions)
Beta: 0.52
52 Week High: $517.74
52 Week Low: $365.21
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 10.33% 9.47%
12 Week 21.08% 18.10%
Year To Date 19.46% 10.33%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
255 EAST FIFTH STREET SUITE 2600
-
CINCINNATI,OH 45202
USA
ph: 513-762-6690
fax: 513-762-6590
None http://www.chemed.com
 
 • General Corporate Information   
Officers
Kevin J. McNamara - Chief Executive Officer; President and Director
Michael D. Witzeman - Executive Vice President; Chief Financial Officer;
Ron DeLyons - Director
Patrick P. Grace - Director
Christopher J. Heaney - Director

Peer Information
Chemed Corporation (CMTI)
Chemed Corporation (CMWLQ)
Chemed Corporation (AHG.)
Chemed Corporation (ROIX)
Chemed Corporation (M.DCE)
Chemed Corporation (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 16359R103
SIC: 8082
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/28/26
Share - Related Items
Shares Outstanding: 13.27
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.52
Market Capitalization: $6,784.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.47%
Current Fiscal Quarter EPS Consensus Estimate: $5.58 Indicated Annual Dividend: $2.40
Current Fiscal Year EPS Consensus Estimate: $22.67 Payout Ratio: 0.12
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.04
Estmated Long-Term EPS Growth Rate: 11.97% Last Dividend Paid: 05/28/2026 - $0.60
Next EPS Report Date: 07/28/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.55
Trailing 12 Months: 25.96
PEG Ratio: 1.88
Price Ratios
Price/Book: 8.00
Price/Cash Flow: 20.72
Price / Sales: 2.67
EPS Growth
vs. Year Ago Period: -0.59%
vs. Previous Quarter: -14.19%
Sales Growth
vs. Year Ago Period: 1.63%
vs. Previous Quarter: 2.84%
ROE
06/30/26 - -
03/31/26 - 27.18
12/31/25 - 25.66
ROA
06/30/26 - -
03/31/26 - 17.38
12/31/25 - 17.24
Current Ratio
06/30/26 - -
03/31/26 - 0.85
12/31/25 - 1.05
Quick Ratio
06/30/26 - -
03/31/26 - 0.83
12/31/25 - 1.03
Operating Margin
06/30/26 - -
03/31/26 - 10.98
12/31/25 - 11.25
Net Margin
06/30/26 - -
03/31/26 - 10.23
12/31/25 - 10.48
Pre-Tax Margin
06/30/26 - -
03/31/26 - 13.73
12/31/25 - 14.06
Book Value
06/30/26 - -
03/31/26 - 63.88
12/31/25 - 69.15
Inventory Turnover
06/30/26 - -
03/31/26 - 213.84
12/31/25 - 208.66
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.11
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - -
03/31/26 - 9.71
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©